FLASHNEWS:

Liven Pharma Reports Narrowed Losses and Revenue Decline in FY26

Karachi: Liven Pharma Ltd. (LIVEN) announced its financial results for FY26, highlighting a significant reduction in net losses despite a decline in revenue. The company reported a net loss of PkR31.1 million, a substantial improvement from the PkR584.5 million loss in the same period last year. This 95% year-over-year reduction was primarily driven by a 90% decrease in administrative expenses and an increase in gross margin to 25.2% from 14.1%.

According to AKD Securities Limited, the company's revenue for FY26 was PkR105.8 million, experiencing a 17% decrease from PkR127.3 million in the previous year. For the first quarter of FY27, Liven Pharma recorded a narrowed net loss of PkR7.4 million, down 76% from PkR30.2 million in the same quarter last year. This improvement was supported by a 62% increase in revenue, reaching PkR14.3 million compared to PkR8.8 million in the prior year's quarter.